ERBB2 and breast carcinoma: Our data show that luminal A/B and normal-like breast cancer subtypes display the highest levels of ERBB4 expression, the HER2-enriched subtype shows intermediate levels, whereas the lowest levels are detected in the basal-like breast subtype (Figure 1E).